Home › Research › Risk factors
Promoting Healthy Aging: Public Health as a Leader for Reducing Dementia Risk
Eva M. J. Jackson, Kelly O’Brien, Lisa C. McGuire, Matthew D. Baumgart, Janelle E. Gore, Katie Brandt, Allan I. Levey, Helen Lamont. Public Policy & Aging Report, 2023-07-15
Topic: Risk, prevention and care in population studies
Plain-language summary
It is estimated that for people aged 65 years and older, the risk of developing Alzheimer’s disease was nearly double for women compared with men (Weinstein et al., 2012). From 2014 to 2050, the overall U.S. population aged ≥65 years is expected to nearly double from 46 million to 88 million (Colby & Ortman, 2015), but some populations will see larger increases than others. These advances demonstrated the value of public health within ADRD policy. When public health and other health leaders assume an equity emphasis for risk reduction and invest in health promotion, there are significant downstream social and economic cost savings and improvements. In July 2021, the subcommittee recommended that the Advisory Council add the drafted sixth goal to the national plan to address risk and protective factors associated with ADRD (Risk Reduction Subcommittee 2021 Proposed Recommendations, 2021).
What this study adds
Evidence grade: Low
This article describes public health efforts and policy recommendations for reducing dementia risk, noting that Alzheimer's risk was nearly double for women compared with men aged 65 and older. It does not report results of a treatment, cure, or prevention trial.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jackson, E. M. J., O’Brien, K., McGuire, L. C., Baumgart, M. D., Gore, J. E., Brandt, K., et al. (2023). Promoting Healthy Aging: Public Health as a Leader for Reducing Dementia Risk. Public Policy & Aging Report. https://doi.org/10.1093/ppar/prad011
Vancouver
Jackson EMJ, O’Brien K, McGuire LC, Baumgart MD, Gore JE, Brandt K, et al. Promoting Healthy Aging: Public Health as a Leader for Reducing Dementia Risk. Public Policy & Aging Report. 2023. doi:10.1093/ppar/prad011. PMID: 37736523.
BibTeX
@article{jackson2023-37736523,
author = {Jackson, Eva M. J. and O’Brien, Kelly and McGuire, Lisa C. and Baumgart, Matthew D. and Gore, Janelle E. and Brandt, Katie and Levey, Allan I. and Lamont, Helen},
title = {{Promoting Healthy Aging: Public Health as a Leader for Reducing Dementia Risk}},
journal = {Public Policy \& Aging Report},
year = {2023},
doi = {10.1093/ppar/prad011},
pmid = {37736523},
url = {https://doi.org/10.1093/ppar/prad011}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- It is estimated that for people aged 65 years and older, the risk of developing Alzheimer’s disease was nearly double for women compared with men (Weinstein et al., 2012).
- From 2014 to 2050, the overall U.S. population aged ≥65 years is expected to nearly double from 46 million to 88 million (Colby & Ortman, 2015), but some populations will see larger increases than others.
- These advances demonstrated the value of public health within ADRD policy.
- When public health and other health leaders assume an equity emphasis for risk reduction and invest in health promotion, there are significant downstream social and economic cost savings and improvements.
- In July 2021, the subcommittee recommended that the Advisory Council add the drafted sixth goal to the national plan to address risk and protective factors associated with ADRD (Risk Reduction Subcommittee 2021 Proposed Recommendations, 2021).
Why it matters
This article describes public health efforts and policy recommendations for reducing dementia risk, noting that Alzheimer's risk was nearly double for women compared with men aged 65 and older. It does not report results of a treatment, cure, or prevention trial.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 16/100
Report — not peer-reviewed. It scored 26 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 25 of the 96 points we could judge it on, which is 26 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Public Policy & Aging Report) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 3 / 10 | Report — not peer-reviewed. Named source is an organizational report, not a journal article. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 14 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.8 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Helen Lamont holds only 5 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37736523) |
| Free to read | 2 / 2 | Free to read |
| Points | 25 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 25 of the 96 points we could judge it on is 26 out of 100. |
| Total | 26 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1093/ppar/prad011
- PubMed: 37736523
- Original source →
- Free full text: Public Policy & Aging Report →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Risk factors from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.